Document Detail


First Canadian experience with high-risk percutaneous coronary intervention with assistance of a percutaneously deployed left ventricular assist device.
MedLine Citation:
PMID:  18987766     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Mechanical assist devices play an increasing role in high-risk percutaneous coronary intervention (PCI) in highly complex and critically ill patients. The Impella Recover LP 2.5 is a minimally invasive left ventricular assist device that is inserted percutaneously via a 13 Fr sheath. The device is engineered to provide a significant increase in cardiac output in patients with severe left ventricular impairment as well as in patients undergoing high-risk coronary intervention, and may provide substantive circulatory support when severe hemodynamic compromise occurs. It can potentially be maintained in situ for five to seven days. Canada's first implantations of an Impella device providing circulatory support in patients undergoing complex, high-risk PCI are reported. Larger studies will be required to identify whether a survival benefit or improvement in left ventricular function can be achieved when using the Impella device to support patients undergoing high-risk PCI or those in cardiogenic shock.
Authors:
Jonas Eichhöfer; Mark Osten; Eric Horlick; Vladimír Dzavík
Related Documents :
312706 - Temporary left ventricular bypass: factors affecting patient survival.
19944326 - Complete recovery from severe myocardial dysfunction in a patient with anorexia nervosa.
17574516 - Initial experiences with the heartmate vented electric left ventricular assist system i...
11899176 - Right ventricular dysfunction and organ failure in left ventricular assist device recip...
11837516 - Plasma n-terminal pro-atrial natriuretic peptide predicts death after premature myocard...
8901756 - Evidence for an involvement of the neutrophil integrin lymphocyte function-associated a...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  24     ISSN:  1916-7075     ISO Abbreviation:  Can J Cardiol     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-06     Completed Date:  2008-12-10     Revised Date:  2010-09-23    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  e82-5     Citation Subset:  IM    
Affiliation:
Division of Cardiology, University Health Network, University of Toronto, Ontario.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged, 80 and over
Angioplasty, Transluminal, Percutaneous Coronary / methods*
Combined Modality Therapy
Coronary Angiography
Critical Illness / therapy
Electrocardiography
Female
Follow-Up Studies
Heart Catheterization / methods
Heart Failure / complications,  diagnosis,  therapy*
Heart Function Tests
Heart-Assist Devices*
Humans
Male
Middle Aged
Myocardial Infarction / complications,  radiography,  therapy*
Ontario
Risk Assessment
Stents*
Stroke Volume
Treatment Outcome
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myocardial bridge: is the risk of perforation increased?
Next Document:  Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therap...